NFKB1 and atherosclerosis: In this regard, the NF-κB signaling pathway, and modulation thereof, has been the subject of numerous studies due to its central role in a number of inflammatory pathologies ranging from, but not limited to, atherosclerosis, diabetes, and rheumatoid arthritis.